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We investigated the fate of the cadaver renal transplant 
done with cyclosporine and predn-isone immunosup-
pression into a recipient who had suffered the loss oj at 
least two prior allografts. Nineteen cadaver renal allo-
grafts were transplanted into 78 recipients. All 78 re-
cipients had previously rejected at least two prior al-
lografts. One of these rejected an allograft done at our 
institution with cyclosporine and prednisone and was 
included a second time in this series when a fourth al-
lograft was received. 
Nine of 79 allograjts were successfully transplanted. 
Average follow-up time was 39 months. Eight allo-
grafts were rejected. One graft was lost to technical 
complications. In one instance, the recipient died with 
a functioning graft. 
Duration of function oj previous allografts was not 
found to be a critical determinant of third or fourth 
graft survival. lfuman leukocyte antigen matching ruas 
not a statistically significant determinant. Panel reac-
tive antibody was higher in those who rejected the third 
or fourth allograft, but not with statistical significance. 
Recipients with the blood type A were less likely to en-
joy successful third or fourth cadaver renal trans-
plantation. We concluded that the "two time loser" 
renal allograft recipient should not be systematically 
denied subsequent transplantation. 
THE PATIENT who suffers loss of a renal trans-
plant to rejection is at increased risk of rejecting a 
subsequent cadaver kidney transplant (CKl) 
performed under azathioprine and prednisone 
immunosuppression (1, 2). Retransplantation 
after two failed transplant attempts has been 
found to have a prohibitive failure rate, and at 
least one center has advocated withholding a third 
transplant from those patients who have a history 
of early rejection of antecedent grafts (3). Cyclo-
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sporine, in conjunction with low dose prednisone, 
has been shown to have superior immunosup-
pressive properties (4). This combination has 
been used for CKT at the University of Pitts-
burgh since 1980 and has been found to yield su-
perior results in patients who have required a 
second attempt at renal transplantation (5). To 
investigate the fate of the third or fourth kidney 
transplant, we reviewed the records of all reci-
pients at our institution who had failed at least 
two previous transplantation attempts and un-
derwent CKT with cyclosporine and prednisone 
immunosuppression (C+ PI). 
MATERIALS AND METHODS 
From February 1981 to February 1985, 16 
patients, each of whom had previously suffered 
two graft failures, underwent CKT at the Uni-
versity of Pittsburgh. An additional two patients 
underwent CKT after each had lost three previ-
ous grafts. One of the patients included in the 16 
who received a third transplant rejected the CKT 
and went on to receive a fourth transplant. With 
the exception of this patient, all of the antecedent 
allografts were done prior to the use of C+PI. 
Review of the 19 instances of CKT done in these 
18 patients ensured a minimum follow-up period 
of one year for each CKT. 
Warm T-cell cross matches between donor and 
recipient were negative in all instances. Human 
leukocyte antigen (HLA) A and B mismatching 
did not preclude transplantation. Immunosup-
pression consisted of cyclosporine and low dose 
prednisone, as previously described (6). 
The records of these 18 patients were reviewed 
to determine the cause of failure for each antece-
dent graft. The HLA mismatches between reci-
pients and their most recent respective allografts 
were reviewed. The blood type of the recipient 
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TABLE I.-HUMAN LEUKOCYTE ANTIGEN, PANEL REACTIVE ANTIBODY, BLOOD TYPE AND CAUSE OF 
ANTECEDENT GRAFT FAILURE IN UNSUCCESSFUL TRANSPLANT GROUP 
_PRA, per cent_ Cause of antecedent 
Previous No. of lILA (A and B) Historical Most Blood type --graft failure __ 
Patient No. transplants matching loci highe.rt recent recipient/donor No.7 No.2 No.3 
1 ..................... . 2 0 80 56 A/A IR AR 
1 ............................ . 3 0 80 56 A/A IR AR AR* 
2...... . .............. . 2 2 99 98 0/0 CR AR 
3 ............................ . 2 1 17 00 A/A CR AR 
4 .......... . 2 1 87 41 A/A CR AR 
5 ............................ . 2 0 22 00 0/0 AR AR 
6. . . . . . . .......... . 2 0 99 68 A/A AR AR 
7 ............................ . 2 2 84 80 A/O TC AR 
Average ........................ . 0.8 71 50 
·Performed with cyclosporine and prednisone immunosuppression. 
AR, Acute rejection; JR, intermediate rejection; CR, chronic rejection; TC, technical complications; HLA, human leukocyte antigen A and B, and PRA, panel 
reactive antibody. 
and each respective donor was noted. In addition, 
the status of presensitization of each recipient, as 
reflected by the panel reactive antibody (PRA) , 
was reviewed. In an effort to determine if any of 
the factors influenced the outcome of a third or 
fourth allograft, the patients who rejected the al-
lografts were compared with those who under-
went successful transplantation. 
RESULTS 
To date, nine of 19 allografts are functioning. 
The duration of graft survival time for these nine 
successful transplants ranges from 13 to 58 
months, with an average of 39 months. Seven pa-
tients rejected a total of eight CKT. Seven of the 
eight CKT were rejected within one month. The 
remaining graft was rejected within one year of 
transplantation. One patient who had previously 
undergone three unsuccessful transplantations 
lost the transplant to technical complications. 
One patient died with a functioning CKT within 
one month of transplantation. The cause of death 
was myocardial infarction and represents the only 
operative mortality. These latter two patients 
were excluded from analysis of the recipients who 
lost the grafts to rejections. The total graft survi-
val rate was 46.0 per cent and the operative mor-
tality rate was 5.3 per cent. 
In Tables I and II, the donor to recipient HLA 
matching loci, the PRA determinations of the re-
cipient and the blood types of each recipient and 
respective donor are tabulated. The number of 
matched HLA (A and B) loci are out of a possible 
four. The highest historical PRA and most recent 
pretransplantation PRA of the patient are both 
recorded. In addition, the cause of failure for the 
antecedent allografts for each recipient is listed. 
The designation "acute rejection" refers to 
those episodes of antecedent graft rejection which 
occurred within three months of the transplanta-
tion. The term "chronic rejection" signifies epi-
sodes of rejection which required the return of the 
recipient to dialysis after one year. To further 
differentiate duration of antecedent graft survival 
time, a classification of "intermediate rejection" 
was used to define those grafts which had been 
rejected between three months and one year after 
transplantation. In one instance, an antecedent 
graft was lost due to the noncompliance of the re-
cipient with the immunosuppressive regimen. In 
another instance, an antecedent allograft was 
sacrificed to rejection by abandoning immuno-
suppression in order to treat a life-threatening 
infection. Two antecedent allografts were lost to 
technical complications. 
In Table I, seven patients who lost the CKT 
done with C+ PI are presented. In Table II, the 
patients who received successful CKT with C+ 
PI are listed. 
The successful transplants were performed 
with a slightly better HLA (A and B) match be-
tween recipient and donor than the unsuccessful 
transplants (1.7 matched loci versus 0.8). The 
average highest historical PRA was greater for 
the recipients who rejected the CKT (71 per cent) 
than it was for those who received successful 
CKT (52 per cent). The average most recent 
PRA was also different between the two groups 
(50 versus 23 per cent). These differences are not 
statistically different. 
Six of eight CKT which were rejected were 
transplanted into recipients with blood type A. 
Only one successful recipient demonstrated this 
phenotype. 
The nine patients who underwent successful 
CKT with C+ PI received a total of 19 antecedent 
allografts. Three had been lost to chronic rejec-
tion, two to intermediate rejection, one graft to 
technical complications and 13 grafts were 
acutely rejected. The seven patients who rejected 
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TABLE n.-HUMAN LEUKOCYTE ANTIGEN, PANEL REACTIVE ANTIBODY, BLOOD TYPE AND CAUSE OF 
ANTECEDENT GRAFT FAILURE IN SUCCESSFULLY TREATED TRANSPLANT GROUP 
_PRA, per cent_ Cause of antecedent 
Previous No. of HLA (A and B) Historical Most Blood type __ graft failure __ 
Patient No. transplants matching loci 
1. ..... . .................. 2 0 
2 .................. .......... . 2 2 
3 ............................. 2 1 
4 ..... ....................... . 2 3 
5 ... . . . . . . . . 3 1 
6 ............................. 2 0 
7 ......................... " .. 2 3 
8 ... ....... . . . . . . . . . . . . . . . . . . . 2 2 
9 ........ .................... . 2 4 
Average ........................ ......... . 1.7 
·Rejected secondary to noncompiiance, five months post-transplant. 
tRejected secondary to withdrawal of immunosuppression during infection. 
highest 
89 
16 
57 
88 
00 
48 
90 
05 
74 
52 
recent recipient/donor No. 7 No.2 No.3 
49 0/0 AR AR 
02 B/B CR AR 
57 0/0 AR AR 
85 0/0 AR JR· 
00 A/A AR AR AR 
10 AB/B AR TC 
00 0/0 AR AR 
00 0/0 CR ARt 
03 0/0 CR IR 
23 
AR, Acute rejection; IR, intermediate rejection; Co~ chronic rejection; TC, technical complications; HLA, human leukocyte antigen A and B, and PRA, panel 
reactive antibody. 
the CKT done under C+ PI received 15 antece-
dent allografts. One of these was the CKT done 
in Patient No. 1 under C+ PI. Three allografts 
had been lost to chronic rejection, one to inter-
mediate rejection, one to technical complications 
and ten were acutely rejected. 
DISCUSSION 
Lower second graft success rates have been 
reported in those patients who reject an antece-
dent first graft within three months. Those reci-
pients who have a history of rejecting the first 
graft after three months have been found to have a 
greater likelihood of success with a subsequent 
CKT (7). In a single center study, it was found 
that the recipient who suffers chronic rejection of 
an allograft (defined as one year of graft function) 
and receives a subsequent allograft fares better 
than the recipient who suffers acute rejection and 
receives a second allograft (8). 
Using conventional immunosuppression, re-
sults with transplantation in the patient who has 
rejected two previous kidneys have been poor. In 
a multicenter study, it has been reported that a 
mere 18 per cent one year graft survival rate can 
be expected if a preceding allograft was rejected 
within three months. In those patients who re-
jected the preceding allograft after one year, re-
transplantation was met with a 50 per cent one 
year graft survival rate (9). Similar observations 
of a single center with a smaller number of pa-
tients have led others (3) to discourage retrans-
plantations if the recipient has a history of early 
rejection of antecedent grafts. Our results, using 
cyclosporine, do not support the distinction be-
tween chronically rejected and acutely rejected 
antecedent grafts. Three of 19 antecedent grafts 
were chronically rejected in the patients who 
went on to successful CKT. Similarly, three of 15 
grafts were chronically rejected in the patients 
who went on to reject a third or fourth allograft. 
The incidence of acute rejection of antecedent 
grafts was 68 per cent in the successfully trans-
planted group. A similar incidence of 67 per cent 
acutely rejected antecedent grafts was found in 
the recipients who rejected a subsequent CKT 
under C+PI. 
In the primary CKT performed under cyclo-
sporine and prednisone immunosuppression, re-
cent PRA levels have been shown to be a signifi-
cant prognostic indicator (10). Recent PRA levels 
have also proved prognostically significant for 
secondary transplants performed with conven-
tional immunosuppression (11, 12). In addition, 
the most recent pretransplant PRA level has been 
shown to predict outcome of the CKT that occurs 
after a previous failed attempt, when the second-
ary CKT is performed with the aid of cyclospor-
ine (10). 
In the patients who undergo a third transplant 
under conventional immunosuppression, popu-
lation size has not been adequate to investigate 
statistical significance of this prognostic indica-
tion (3) . Although our successful transplant 
population enjoyed a lower historical and recent 
PRA than those who failed transplantation, these 
differences are not significant. Determination of 
the significance of these differences must await 
accumulation of a larger patient population. 
Degree of HLA matching between donor and 
recipient was not a statistically significant factor 
in determining outcome of the third or fourth al-
lograft in this small series. It is interesting to note, 
however, that the three grafts which matched the 
HLA loci of the recipient at three or four posi-
tions were all successfully transplanted. None of 
the failed grafts matched the recipients at more 
than two loci. 
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One apparent difference between the recipients 
who received a successful CKT and those who 
rejected the CKT is the prevalence of the blood 
type A in the group who failed CKT. Eight allo-
grafts transplanted under cydosporine and 
prednisone immunosuppression were rejected. Of 
these eight, six were transplanted into recipients 
with the blood type A. Nine allografts were suc-
cessfully transplanted. Of these nine, only one 
was transplanted into a recipient with the blood 
type A. This may reflect dependency upon a 
smaller donor pool for the potential recipient with 
the blood type A. This smaller pool may yield al-
lografts with a lesser chance of matching the re-
cipient at antigens other than blood type. In no 
instance did an A type recipient receive a CKT 
with greater than 2 HLA (A and B) matching 
loci. While the HLA (A and B) loci themselves 
may not statistically influence the graft outcome, 
this mismatch may reflect mismatches at other 
significant loci. 
SUMMARY 
In order to investigate the fate of the CKT 
transplanted under cyclosporine and prednisone 
immunosuppression into a recipient who has 
suffered the loss of at least two prior allografts, 
we reviewed our experience with 19 such CKT 
into 18 recipients. One recipient rejected a CKT 
which was done with C+ PI and went on to have a 
fourth allograft. Nine of 19 grafts were success-
fully transplanted with an average follow-up pe-
riod of 39 months. Eight allografts were rejected. 
One graft was lost to technical complications. In 
one instance, the graft was functioning one month 
postoperatively but the recipient died of a myo-
cardial infarction. 
Unlike others, we could not identify a poorer 
outcome for those CKT transplanted into a reci-
pient who had previously rapidly rejected a allo-
graft. Although function duration of prior allo-
graft might be a determinant of third or fourth 
graft survival, our data indicates that it is not a 
critical determinant. Since few institutions will 
accumulate large numbers of patients in whom 
two previous grafts have failed, it is premature to 
exclude such patients from consideration for 
other transplants. Optimal tissue matching, a 
goal which is difficult to achieve in these high 
PRA patients, might improve graft survival. 
Although the average HLA (A and B) match 
for the successfully transplanted CKT was 
greater than that for the failed CKT, this differ-
ence was not statistically significant in our small 
patient population. An interesting finding of un-
known significance is the poorer prognosis for the 
recipient with blood type A who loses two allo-
grafts. It would appear from our data that these 
patients are less likely to enjoy a successful third 
or fourth allograft under C+ PI. 
In conclusion, the graft survival time for pa-
tients failing two or more prior grafts is about 50 
per cent with cyclosporine and steroids, signifi-
cantly less than the graft survival time for patients 
receiving the first transplant. Nevertheless, such 
patients should not be systematically denied sub-
sequent transplants. 
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